drugset

drugset / Trial / NCT07172360

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

NCT07172360 ↗

Phase 3 Recruiting 420 enrolled Jiangsu vcare pharmaceutical technology co., LTD

RandomizedParallel-groupDouble-blindTreatment

Summary

This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.

Timeline

Start: 2025-12-26
Primary completion: 2027-08-30
Completion: 2027-08-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VC005	Unknown	—	—

Indications